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Introduction

Calcium pyrophosphate dihydrate (CPPD) crystal
deposition disease is characterized by depo sits of triclinic (t)
and monoclinic (m) CPPD crystals in articular and
fibrocartilage. Many investigators have attempted to model
CPPD crystal growth using both solution and a variety of gel
systems. We have investigated the effect of type I collagen
fibrils on CPPD crystal nucleation and growth using an ionic
diffusion model. Collagen was isolated from porcine menisci
using a pepsin solubilization procedure and gelled in three
layers, with one containing JO mM pyrophosphate (PPi) plus
physiologic ions, the middle containing only the ions, while
the third contained 25 mM Ca plus physiologic ions.
Initially , amorphorous calcium pyrophosphate formed at the
Ca-PPi interface . Monoclinic CPPD crystallized in 6 weeks
when the [Ca] was between 2 and 3 mM and the [PPiJ was
between 50 and 75 µM . At 13 weeks, t-CPPD formed when
the [Ca] was also between 2 and 3 mM, but the PPi was less
than 25 µM. One of the most striking differences between
this system and all previous solution and gel model systems
is the total absence of orthorhombic calcium pyrophosphate
tetrahydrate (o-CPP1) from the gels made of collagen fibrils
in near native conformation . Further, crystals of t-CPPD
appear as large single crystals with the classic prismatic
growth habit observed in vivo, and crystals of m-CPPD also
evidence the in vivo rod habit. 1ncontrast, the crystal growth
habits of t-CPPD, m-CPPD, and o-CPPT grown in all of the
other model systems never matched that observed in vivo.
When compared to the previous studies, these results,
particularly the crystal growth habit data, suggest that the
native collagen fibrils themselves can nucleate CPPD crystal
formation.

Calcium pyrophosphate dihydrate (CPPD) crystal
deposition disease is characterized by CPPD crystal deposits
in articular and fibrocartilage, especially knee menisci [26] .
To date, there is no way to halt the progressive deposition of
CPPD crystals nor is there a clinically suitable method of
removing those already deposited [26]. The pathogenesis of
cartilage degeneration in this arthritic disease is thought to
include an amplification loop [12] ; damaged cartilage is
predisposed to CPPD crystal deposition which then induces
further enzymatic or mechanical damage to the cartilage . In
familial CPPD crystal deposition disease, changes have been
noted in the cartilagenous matrix which antedate the formation
of CPPD crystals [4] . CPPD crystals induce both
synoviocytes [ JO] and chondrocytes [ 11] in cell culture to
release collagenase and neutral protease.
This selfperpetuating loop could explain many of the clinical
observations seen in patients with CPPD crystal deposition
disease.
The initial deposits of CPPD appear to be located at
the lacunar margins of degenerating chondrocytes in areas of
reduced safranin O staining, indicative of reduced acid
mucopolysaccharide concentrations [ 15], whereas larger
deposits are associated with cellular necrosi s in the periphery
[3]. CPPD deposits have also been observed on collagen
bundles [2]. Although some crystals occur in areas of
degeneration, others are found in cartilage possessing normal
histology . The apparent in vivo preference of CPPD crystals
for collagen denuded of proteoglycan suggests that the native
collagen fibrils (or their accompanying macromolecules) may
serve as nucleating templates for crystal formation.
The mechanism of CPPD crystal deposition in
cartilage is not understood, in part because CPPD deposition
apparently occurs in an undersaturated environment. There
does not appear to be any gross disturbance in the systemic
metabolism of inorganic pyrophosphate (PPi) in patients with
CPPD crystal deposition disease [25]. Even in the elevated
state, the [Ca] and [PPi] in the synovial fluid are
undersaturated [l]. Thus, the need for an in vitro model for
CPPD crystal deposition has long been recognized .
Although almost 30 different Ca and mixed Ca
pyrophosphates have been synthesized [16], only two distinct
crystallographic dimorphs of CPPD have been observed in
vivo: triclinic (t) and monoclinic (m) CPPD . In menisci,
which is the most common crystal deposition site [l], tCPPD predominates in a ratio of 3:1 [21]. Since in vitro
preparations of t-CPPD and m-CPPD necessitate a pH of 3.0
and high concentrations of Ca and PPi [20], solution studies
modeling CPPD deposition have attempted to determine the
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[Ca] and [PPi] necessary for crystal nucleation and growth at
physiologic pH [7, 8, 9, 14].
CPPD crystal growth has also been modeled using
biological grade gelatin [23], silica gel [23], polyacrylamide
gel [13], and whole cartilage [24], however none of these
models were able to reproduce t-CPPD and m-CPPD crystal
growth at physiologic conditions. We successfully grew tCPPD and m-CPPD at physiologic ionic concentrations using
biological grade gelatin in an ionic diffusion model [18, 19].
However, other crystalline species were also formed and both
t-CPPD and m-CPPD grew in non-phy siologically observed
crystal growth habits, i.e . as long needles . These studies
did, however, indicate that the time of incubation of Ca and
PPi ions was a critical parameter in determining the type of
crystal formed, and that the formation of the two in vivo
crystals was mediated by the formation of intermediate
crystalline materials and the subsequent dissolution of those
species. The formation/dissolution/reformation mechanism
allowed for a very localized ionic concentrating process to
occur.
Although the biological grade gelatin system allowed
for a much better understanding of the possible kinetics of
CaPPi crystal growth, the question arises as to whether native
collagen fibrils act differently than the denatured form of
collagen in mediating the crystal growth process . Therefore,
we investigated the effect of type I collagen fibrils on CPPD
crystal nucleation and growth using our ionic diffusion
model.

Gel Preparation
The gels were prepared as 3 layers in glass tubes (8
mm i.d. x 100 mm, total volume 5 ml) . The ends of the
tubes were stoppered with serum caps . Three collagen
solutions were prepared in 0.05 M Hepes buffer (pH 7.4) at a
concentration of 2.5 mg/ml . The bottom layer consisted of I
ml of the Ca solution (25 mM CaCl2, 78 mM NaCl, 4.5 mM
KC!, 1.0 mM MgSO4), the middle layer consisted of 2 ml of
only the secondary ions (128 mM NaCl, 4.5 mM KC!, 1.0
mM MgSO4,), and the top layer consisted of 1 ml of the PPi
solution (10 mM N~P2O7, 88 mM NaCl, 4.5 mM KC!, 1.0
mM MgSO4) . Sodium azide (15 mM) was included in all
layers to prevent fungal growth . The solutions were layered
separately while cold and incubated at 37° C to gel before the
next layer was poured. The total length of the gel was 8 cm.
The gel tubes were prepared in triplicate, incubated at
37° C, and harvested at 14 preset times over a 6 month
period. In order to facilitate their handling at harvest, the gel
tubes were immersed in an acetone-dry ice bath for 20
seconds. This short cold treatment kept the collagen gels
from melting while they were being separated but did not
induce any crystal growth. The gel was then pushed from_the
tube in 1 cm increments which were sliced off and placed mto
clean tubes for the analyses described below.
Crystal Characterization
The collagen gels were allowed to melt at room
temperature and the crystalline material was isolated by
centrifugation, washed twice with doubly distilled water, and
air-dried. The supematants from the gels were saved for Ca
and PPi analyses as described below. All crystalline samples
were characterized using copper radiation generated by a 12
kW high brilliance rotating anode x-ray generator (Rigaku,
Japan) . Samples were diffracted using a germanium crystal
monochromated Guinier powder diffraction camera (Huber
Instruments, West Germany). Diffraction patterns were
compared to those of known pyrophosphate structures [16].
The term amorphous calcium pyrophosphate (a or a-CaPPi )
was operationally defined as the pre sence of a significant
amount of precipitate with a diffraction pattern containing a
broad diffu se background but with no distinct diffraction
lines. Representative samples were characterized further with
scanning electron microscopy (Model 1200, Advanced Metals
Research Corp. , Bedford, MA) .
Pyrophosphate assay
Pyrophosphate determination s were_carried out ?Y
using the assay kit (P-7275, Sigma Chemical, St. Louis ,
MO). Aliquots of the meniscus gel were diluted 1: 10 bef<?re
analyses. In addition to determini _ng the [PPi] at each pom~
within the gel , we also determined the amount of PPi
hydrolysis which had occurred as the experiment progressed
by assaying the PPi level in standard collagen gel tubes ,
which contained only the PPi solution and were prepared at
the beginning of the experiment. Hydrolysis was not a
significant problem .
Calcium assay
Calcium was determined by atomic absorption
analysis (Model AA-1475, Varian As_sociates_,Palo A~to,
CA). A 0.30 ml aliquot of the gel was diluted with a solution
containing 1% LaCl3 in 5% HCl according to standard
procedures. Concentrations were determined using a 1000
µg/ml Ca standard in 2% HCl (Fisher Scientific, Itasca, IL)
diluted as above.
Preparation of Ion Gradient Contour Plots
The [Ca] was plotted as a function of tube position
and time. Contours were drawn at levels of 1 mM up to 10
mM, after which they were contoured at 5 mM intervals. The
[PPi] contour plot was constructed in the same manner,
except that the contour levels were 0.025, 0.05, 0.10, 0.25,

Materialsand Methods
Collagen purification
Type I collagen was isolated from porcine meniscus
using a pepsin solubilization procedure [22]. Briefly, the
menisci were dissected from the knee joints within 24 hours
of slaughter of 4 to 6 month old pigs (Patrick Cudhay,
Cudhay , WI) . Standard surgical procedures were used to
separate the medial and lateral menisci from each joint. The
menisci were trimmed of surrounding fat, ligaments, and the
opalescent anterior edge which is composed of both type I
and II collagens . The menisci were thinly sliced, rinsed with
a 0.9% saline solution at 4 °C, and freeze milled (Spex
Industries, Metuchin, NJ) for a short time. In order to extract
the proteoglycan prior to the collagen isolation procedure,
cartilage fragments were then extracted twice with 20
volumes to weight of 4 M guanidine, 0.05 M Tris-HCl at pH
7.4 at 4 °C for 48 hours. Centrifugation between extractions
was carried out at 30,000 x g. The precipitated fragments
were then stirred for 15 hours at 4 °Cina sufficient volume
of cold 0.5 M acetic acid containing 1 mg/ml pepsin to
maintain a collagen to pepsin ratio of 10: I. The suspension
was centrifuged at 35,000 x g for I hour at 4 °C. The
extraction procedure was repeated, and the supernatants
pooled. The soluble collagen was precipitated by the addition
of sufficient crystalline NaCl to give a final concentration of
2.0 M and then collected by centrifugation at 35,000 x g for 2
hours at 4 °C. The precipitated type I collagen was then
redissolved in 1.0 M NaCl, 0.05 M Tris-HCI at pH 7.5 and
dialyzed overnight against this same solution . Any
precipitated material was removed by centrifugation at 35,000
x g and discarded . The type I collagen was again precipitated
overnight by the addition of crystalline NaCl to a final
concentration of 4.0 M. Then, the solution was centrifuged
for 2 hours at 35,000 x g, redissolved in 0.5 M acetic acid,
dialyzed against 0.05 M acetic acid and then lyophilized .
SDS gel electrophoresis [5] showed the collagen to be pure
type I.
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Figure 1: The kinetic map of CPPD crystallization in pepsin
solubilized porcine meniscus type I collagen gels. The [Ca]
and [PPi] ionic gradients have been contoured as a function
of time and tube position and have been overlayed with the
crystal types observed. The [Ca] has been contoured with
dashed lines and the [PPi] is denoted with solid lines. The
[Ca] has been contoured at 1 mM levels below 10 mM and at
5 mM levels above 10 mM . The [PPi] has been contoured at
0.025, 0.05, 0.075, 0.10, 0.25, 0.50, 0.75, 1.0 mM and
then at 1 mM increments up to 10 mM . Tubes were prepared
at [Cainitiall = 25 mM and [PPiinitiall = 10 mM.

0.50, 0.75, 1.0 mM and then at 1 mM increments up to 10
mM, and the two plots superimposed photographically . The
crystals which had been identified at each tube position and
time point were then added to the composite ionic gradient
plot.

Results
Figure 1 shows the ionic gradient plots of the [Ca]
and [PPi] and the crystals formed in the gels. A diffuse
amorphous band in the center of the gel was observed in 2
days which corresponded to the Ca/PPi ionic interface.
Amorphous CaPPi formed when [Ca] was between 1 and 3
mM and when [PPi] was between 0.1 and I mM . This
diffuse band spread throughout the tube within 2 weeks, after
which time the [Ca] and [PPi] fell to physiologic levels.
At 3 to 4 months , most of the diffuse band had
disappeared, leaving a clear gel which contained large clumps
of crystals which were identified as t-CPPD and m-CPPD .
Monoclinic CPPD crystallized .first in 6 weeks when the [Ca]
was 2 mM and the [PPi] was between 50 and 75 µM .
Triclinic CPPD first formed at 13 weeks when the [Ca] was
also 2 mM, but the [PPi] was less than 25 µM . As shown in
Figure 2, the t-CPPD crystals which were isolated at 15
weeks had the very distinctive prismatic growth morphology,
while the crystal growth habit of m-CPPD was rod shaped.
There were numerous t-CPPD and m-CPPD crystals seen in
the sample view ed and no other growth habits were
observed . The primary crystal growth faces of t-CPPD are
the { 100), the {011}, and the (001} [16,17], while those of
m-CPPD are the {100), the {010), and the {001} [16].
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Previous solution studies have shown that, although
other calcium pyrophosphates would grow at physiologic
ionic concentrations, t-CPPD and m-CPPD would not.
Heam and Russell [14] found by optical microscopy that at
physiologic [Ca] and [PPi], the first species to form were an
amorphous material when physiologic [Mg] was present and
orthorhombic calcium pyroph osphate tetrahydrate (o-CPPT)
when there was no Mg. Cheng and Pritzker [7] found that
for t-CPPD and m-CPPD crystal formation in solution, the
PPi concentration must be greater than 1 mM and 3.2 mM,
respectively. The mean PPi level in normal synovial fluid is
3 µM [26] and 10 µM in patient s with CPPD crystal
deposition disease [27]. At physiologic levels of magnesium
and phosphate, a-CaPPi formed, but neither t-CPPD normCPPD would form (7, 8].
In our previous biological grade gelatin gels [ 18, 19],
the diffuse band at the Ca/PPi interface was present at early
times and always tran sformed from a-CaPPi to o-CPPT
within the first few days of incubation . In contrast , in this
study using meniscus collagen gel, thi s band remained
amorphous throughout the entire experiment. Similar to the
biological grade gelatin studies, m-CPPD was identified
earlier than t-CPPD .
One of the most striking differences between this
system and previous solution and gel model systems is the
total absence of o-CPPT from the native collagen gels as
compared to all the other model studies . Further , crystal
morphology is more sensitive to subtle changes in the
crystallization conditions than is crystal form . Using the
native type collagen gels (Figure 2), crystals of t-CPPD
appear as large single crystals with the classic prismatic
growth habit observed in vivo [6], and cry stals of m-CPPD
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Figure 2: A scanning electron micrograph showing the
prismatic crystal growth habit of t-CPPD crystals (large
arrow) and the rod crystal growth habit of m-CPPD crystals
(small arrows) observed in layer 3 after 15 weeks of
incubation. These crystal growth morphologies are identical
to those observed in vivo. Bar is 25 µm.
have the classic rod habit. In contrast, the crystal growth
habits of t-CPPD, m-CPPD, and o-CPPT grown in biological
gelatin model systems were always needles [18, 19].
The ionic diffusion in collagen model system
described in this study appears to be the most reasonable
model system to date in that it has produced only crystals of
a-CaPPi, t-CPPD and m-CPPD . Although the pepsin
solubilizing procedure removes the telopeptides from the
collagen molecules, it maintains near native conformation of
the collagen fibrils themselves . The crystals were grown in
the most nearly physiologic environment of all the model
systems. Finally, the crystal growth habits of both t-CPPD
and m-CPPD grown in the native collagen gel system match
those observed in vivo. When compared to the previous
studies , these results, particularly the crystal growth habit
data, would seem to indicate that the native collagen fibrils
themselves can nucleate CPPD crystal formation .
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tails by acid solub ilization versus the conformation of
collagen isolated from fibrocartilage by pepsin solubilization.

K,P,H,Prjtzker;The authors suggest that type I collagen
nucleates crystal formation. The evidence for this inference is
not clear. It is possible to grow t-CPPD and m-CPPD in
solution and gels by other methods . In these systems, the
CPPD crystals can have similar morphology to in vivo
crystals .
Authors;We agree that the evidence which suggests that
type I collagen nucleates CPPD crystal formation is primarily
negative, i.e. it is based on the absence of a result rather the
presence of concrete data . However, it is a very compelling
argument when all the data are reviewed together . It is
significant that only t-CPPD, m-CPPD, and a-CaPPi were
formed by ionic diffusion of physiological levels of Ca and
PPi in the presence of type I collagen, while other nonphysiologic calcium pyrophosphates were identified in all of
the other previous crystal growth experiments . This fact,
coupled with the fact that the characteristic crystal growth
habits of t-CPPD and m-CPPD only have been observed in
this study and in no other studies, has formed the basis for
this inference . We are currently conducting experiments to
characterize and quantitate the possible nucleating potential of
type I collagen in a more positive way.

Discussionwith Reviewers
K,P,H,Pritzker;This paper describes the formation

R, Terkeltaub:
Is there any difference from the results in
Figure 1 when different procedures are used to isolate type I
collagen from porcine meniscus?
Authors;There is no other way to isolate type I collagen
from meniscus. The more gentle isolation procedures used to
isolate type I collagen from rat tails will not yield any collagen
when applied to cartilagenou s tissues. However, we are
currently investigating the difference s in CPPD crystal
growth in gels made of pepsin solubilized meniscus collagen
and acid solubilized rat tail collagen.

of
m-CPPD and t-CPPD in an in vitro collagen gel system .
Although the system is different , the results appear to be
substantially similar to those recently published (Hunter GK,
Grynpas MD, Cheng P-T, Pritzker KPH (1987) Effect of
glycosaminoglycans on calcium pyrophosphate crystal
formation in collagen gels. Calcif Tissue Int il, 164-170).
Authors; We disagree that these are similar to those of
Hunter, et. al. First, their experiments were conducted at a
Ca:P ratio of 2: 1, rather than at the physiological ratio which
is in the range of 150:1. The [Ca] and [PPi] which we have
investigated in this study not only covered physiological
ratios, but also included physiological concentrations.
Hunter , et.al. did not publish the crystallographic
identification of the crystalline precipitates formed in their
study. Using the three x-ray diffraction patterns which they
published instead, we have determined that the crystals that
they grew at 1.6 mM Ca and 0.8 mM PPi were, in fact, pure
o-CPPT. Also, based on their published patterns, an
unknown calcium pyrophosphate crystal was the sole
crystalline product formed both at 1.6 mM Ca, 0.8 mM PPi,
0.32 mM Mg and at 40 mM Ca, 25 mM PPi, 8 mM Mg. We
have previously reported and characterized this same
unknown calcium pyrophosphate crystal, labelling it as
Unknown B [19] . Using energy dispersive x-ray
microanalysis , we found that this crystalline unknown has an
atomic ratio of 0.69:0.08: 1.0 for Ca:Na :P.
Finally, Hunter, et. al. described the crystal growth
habit as "spherical clusters of needle-shaped crystals". Thus,
their results form a very striking contrast to those presented
here. There are two possible explanations for the differences
in the results between their study and ours even though both
experiments were conducted with type I collagen in nearnative fibril conformation . One is the differences in
experimental conditions and set-ups. Their super physiologic
ionic concentration and Ca :PPi ratios has already been
discussed. Another experimental difference is in the
geometry of the diffusion . In their system, high PPi
concentrations were incorporated into a collagen gel and a
solution containing high Ca concentrations was layered
directly on top of the gel. Another possible contributing
factor accounting for these differences may be related to
differences in the conformation of collagen isolated from rat

R, Tawashj:The

fact that different faces of the m-CPPD
and t-CPPD crystals are developed in the native collagen fibril
gel system suggests that the structure of collagen fibrils as
well as the presence of other impurities (e.g. sodium azide)
are responsible for the direction of growth. I wonder how
the growth process will proceed in the absence of 15 mM
sodium azide, if growth was conducted under asceptic
conditions.
Authors;All of the gel studies conducted in references 18
and 19 were also conducted in the presence of sodium azide.
The only previously published report on the formation of tCPPD and m-CPPD at physiologic levels of calcium and
pyrophosphate was in one of our previous ionic diffusion
experiments using biological gelatin [18]. In this experiment,
the sodium azide concentration was 30 mM . This sample of
t-CPPD and m-CPPD also contained o-CPPT. In the
biological gelatin experiment, the crystal growth habits of all
three crystals were indistinguishable from each other, as they
all grew either as needles and as clumps of needles radiating
from a single point.

TerkeUaub:
Have you evaluated collagen isolated from
animals with experimental degenerative joint disease? What
are the effects of proteolytic collagen peptides or synthetic
collagen oligopeptides on CPPD crystal nucleation in this
model? Can proteoglycans native to articular cartilage or the
extent of proteoglycan polymerization influence CPPD crystal
nucleation in this model?
Authors;All of these questions are very important to our
understanding of the pathogenesis of CPPD crystal
deposition disease . Currently, we are investigating the
possibility that it is the method of collagen extraction, i.e. the
R,
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nature of the collagen degradation, which may play a role in
the apparent potential for type I collagen to nucleate CPPD
crystals. These other questions will be addressed in future
studies.

180

